Furthermore, our data showed that the percentages of CD8+IL-10+ and CD8+IL-4+ T cells were significantly higher in advanced compared to lower stages in patients with HNSCC (P = 0.003 and P = 0.043, respectively, Fig. 6). This evidence concerns the gene IL10 and head and neck squamous cell carcinoma.